Article contents
A Controlled Study of the Effectiveness of Trifluopromazine Hydrochloride
Published online by Cambridge University Press: 08 February 2018
Extract
Vespral, chemically designated as 10-(3-dimethylaminopropyl-2-trifluoro-methyl)-phenothiazine hydrochloride, or trifluopromazine hydrochloride is a new ataractic drug which has only recently become available in this country. A clinical field trial with Vespral has been reported in a previous issue of this journal (1). It was then suggested that the drug was most effective in the treatment of psychotic disorders, schizophrenia in particular. The aim of this study was to evaluate, with some claim to objectivity, the effectiveness of the administration of trifluopromazine hydrochloride on the behaviour of a small population of chronic schizophrenic patients.
- Type
- Original Articles
- Information
- Copyright
- Copyright © Royal College of Psychiatrists, 1959
References
- 3
- Cited by
eLetters
No eLetters have been published for this article.